Olema Pharmaceuticals Inc
NASDAQ:OLMA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Olema Pharmaceuticals Inc
NASDAQ:OLMA
|
US |
|
C
|
Compagnie de Saint Gobain SA
XHAM:GOB
|
FR |
|
NIO Inc
NYSE:NIO
|
CN |
|
B
|
Banco Santander SA
DUS:BSD2
|
ES |
|
P
|
Panasonic Holdings Corp
F:MAT1
|
JP |
|
P
|
PICC Property and Casualty Co Ltd
F:PJC
|
CN |
|
Grupo Aeroportuario del Pacifico SAB de CV
BMV:GAPB
|
MX |
|
Kraft Heinz Co
NASDAQ:KHC
|
US |
|
Procter & Gamble Co
NYSE:PG
|
US |
|
Ameris Bancorp
NYSE:ABCB
|
US |
|
E
|
Endeavour Silver Corp
NYSE:EXK
|
CA |
|
Resmed Inc
NYSE:RMD
|
US |
|
C
|
Cardinal Health Inc
SWB:CLH
|
US |
|
Nippon Sanso Holdings Corp
OTC:TYNPF
|
JP |
|
U
|
Unum Group
DUS:UUM
|
US |
|
F
|
Fuji Electric Co Ltd
DUS:FJE
|
JP |
Bankruptcy Probability
Olema Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Olema Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Olema Pharmaceuticals Inc
NASDAQ:OLMA
|
899.9m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
462.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
206.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
180.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
131.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
82.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
58.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
49.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
43.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Olema Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Olema Pharmaceuticals Inc has total debt of 3m USD. This includes both short-term (0 USD) and long-term (3m USD) debt.
You can find a full breakdown on its Balance Sheet.